Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04624126 · ClinicalTrials.gov registry record · NA
External Device for Erectile Dysfunction (3D-Erect)
A NA study of Erectile Dysfunction and Impotentia Erigendi, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT04624126: Recruiting NA study of Erectile Dysfunction and Impotentia Erigendi, sponsored by Stanford University.
NCT04624126 is a NA study of Erectile Dysfunction and Impotentia Erigendi that is actively recruiting participants, run by Stanford University. The registered enrollment target is 9 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04624126, a NA study of Erectile Dysfunction and Impotentia Erigendi, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).
Primary Outcome
score 0 to 30 with higher score meaning overall better erectile function
Conditions Studied
Interventions
- DEVICE 3D-Erect
Study Locations (1)
California
- Stanford Health Care, Stanford Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-07-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT04624126 shows while recruiting
NCT04624126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which 3D-Erect is the first listed.
NCT04624126 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04624126 about?
NCT04624126 is a clinical study titled "External Device for Erectile Dysfunction (3D-Erect)". The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).
What is the current status of trial NCT04624126?
This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2021-07-10. Estimated completion is 2026-12.
What conditions does trial NCT04624126 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Impotentia Erigendi.
What interventions are being tested in trial NCT04624126?
The interventions under investigation include: 3D-Erect (DEVICE).
Who is sponsoring clinical trial NCT04624126?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04624126 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04624126's enrollment target sits among peer trials
9 31st of 33 higher than 3 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI